CARNA BIOSCIENCES INCCARNA BIOSCIENCES INCCARNA BIOSCIENCES INC

CARNA BIOSCIENCES INC

No trades
See on Supercharts

4572 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Carna Biosciences, Inc. engages in the drug discovery business. It operates through the Drug Discovery Support and Drug Discovery and Development segments. The Drug Discovery Support segment provides drug discovery supporting products and services such as kinase protein, profiling services, assay development, crystallography, and cell-based assay services. The Drug Discovery and Development segment develops new medicines for the treatment of cancer and inflammatory diseases using the kinase drug discovery platform called QuickScout. The company was founded on April 10, 2003 and is headquartered in Kobe, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4572 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company